Cavaillès V, Gompel A, Portois M C, Thénot S, Mabon N, Vignon F
Inserm Unit 540, Molecular and Cellular Endocrinology of Cancers, 60 rue de Navacelles, 34090 Montpellier, France.
J Mol Endocrinol. 2002 Jun;28(3):165-75. doi: 10.1677/jme.0.0280165.
Intranasal administration of hormone replacement therapy presents an original plasma kinetic profile with transient estrogen levels giving rise to the concept of pulsed therapy. To further understand the molecular effects of this new therapy, we have compared the effects of pulsed and continuous estradiol treatments on two critical aspects of estradiol action: gene expression and cell proliferation. Cells were stimulated with estradiol as 1-h pulsed or 24-h continuous treatments at concentrations such that the 24-h exposure (concentration x time) was identical in both conditions. In MCF7 cells, the transcriptional activity of estrogen receptors (ER) on a transiently transfected responsive estrogen response element-luciferase reporter construct was shown to be drastically (approximately 10-fold) and similarly stimulated after both treatments. Moreover, the increased mRNA expression of three representative estradiol-sensitive genes (pS2, cathepsin D, progesterone receptor), evaluated by Northern blot, was identical after 1-h pulse with 7 nM estradiol or continuous treatment with 0.29 nM estradiol with the same kinetic profile over 48 h. Proliferation was quantified by a histomorphometric method on primary cultures of human normal breast cells from reduction mammoplasties and using a fluorescence DNA assay in six human breast cancer cell lines which were ER positive or negative. After a 7-day treatment period, estradiol had no effect on the proliferation of the three ER negative cell lines (BT20, MDA MB231, SK BR3) but significantly stimulated the proliferation of the normal cells and of the three tumoral hormone-sensitive cell lines (MCF7, T47D, ZR 75-1); both hormone treatments producing the same increases in cell growth. In conclusion, we have shown that the genomic or proliferative effects of estradiol were identical with pulsed or continuous treatments, thus indicating that estrogenic effects are not strictly related to concentrations but rather to total hormone exposure.
经鼻给予激素替代疗法呈现出一种独特的血浆动力学特征,其雌激素水平短暂波动,由此产生了脉冲疗法的概念。为了进一步了解这种新疗法的分子效应,我们比较了脉冲式和持续性雌二醇治疗对雌二醇作用的两个关键方面的影响:基因表达和细胞增殖。细胞分别接受1小时脉冲式或24小时持续性雌二醇处理,两种处理的浓度使得24小时暴露量(浓度×时间)在两种情况下相同。在MCF7细胞中,两种处理后,雌激素受体(ER)对瞬时转染的反应性雌激素反应元件 - 荧光素酶报告构建体的转录活性均显著(约10倍)且相似地受到刺激。此外,通过Northern印迹评估的三个代表性雌二醇敏感基因(pS2、组织蛋白酶D、孕激素受体)的mRNA表达增加情况,在7 nM雌二醇1小时脉冲处理后与0.29 nM雌二醇48小时持续处理后相同,且具有相同的动力学特征。通过组织形态计量学方法对来自缩乳术的人正常乳腺细胞原代培养物进行增殖定量,并在六种雌激素受体阳性或阴性的人乳腺癌细胞系中使用荧光DNA测定法。经过7天的治疗期,雌二醇对三种雌激素受体阴性细胞系(BT20、MDA MB231、SK BR3)的增殖没有影响,但显著刺激了正常细胞和三种肿瘤激素敏感细胞系(MCF7、T47D、ZR 75-1)的增殖;两种激素处理对细胞生长的促进作用相同。总之,我们已经表明,脉冲式或持续性处理时,雌二醇的基因组效应或增殖效应是相同的,这表明雌激素效应并非严格与浓度相关,而是与总激素暴露量相关。